Related Experiment Videos
Synthetic mycoplasma-derived lipopeptide MALP-2 induces maturation and function of dendritic cells
Henning Weigt1, Peter F Mühlradt, Andreas Emmendörffer
1Fraunhofer Institute of Toxicology and Experimental Medicine, Hannover, Germany. weigt@item.fraunhofer.de
Abstract:
Dendritic cells (DC) modulate immune responses depending on the nature of the antigens. Receptors capable of discriminating these antigens on the basis of the pathogen-associated molecular patterns (PAMP) belong to the Toll-like receptor (TLR) family. The macrophage-activating lipopeptide 2 kDa (MALP-2), a synthetic lipopeptide derived from Mycoplasma fermentans, signals through TLR-2 and TLR-6. The aim of this study was to examine whether MALP-2 can modulate the functional properties of human monocyte-derived DC. The effects of this treatment were compared to those of the TLR-4 agonist lipopolysaccharide (LPS). To ensure clinical applicability, DC were generated under serum-free conditions. MALP-2 and LPS stimulation induced the expression of CD83 and increased the expressions of CD80, CD86, HLA-ABC and CD40. Furthermore, both substances decreased the endocytotic capacity of DC and induced the release of bioactive TNF-alpha and IL-10, whereas LPS additionally increased IL-12 release. Pretreatment with both substances boosted the allostimulatory capacity of DC. In a coculture with autologous lymphocytes, either MALP-2 or LPS pretreated DC induced a marked proliferation of lymphocytes, but only DC prestimulated with MALP-2 activated lymphocytes to produce the cytokines IL-4, IL-5 and IFN-gamma. No polarisation of lymphocytes into T-helper (Th)1 or Th2 was detected. These data indicate that MALP-2 is a potential candidate to modulate DC for clinical applications.
Insights
Macrophage-activating lipopeptide 2 kDa (MALP-2) modulates human dendritic cells (DC) function, enhancing their ability to stimulate lymphocytes. MALP-2 shows potential for clinical applications in modulating immune responses.
Area of Science:
- Immunology
- Cell Biology
- Molecular Medicine
Background:
- Dendritic cells (DC) are crucial for immune response modulation.
- Toll-like receptors (TLR) recognize pathogen-associated molecular patterns (PAMPs).
- Macrophage-activating lipopeptide 2 kDa (MALP-2) signals via TLR-2 and TLR-6.
Purpose of the Study:
- To investigate MALP-2's effect on human monocyte-derived DC functional properties.
- To compare MALP-2's effects with lipopolysaccharide (LPS), a TLR-4 agonist.
- To assess clinical applicability by generating DC under serum-free conditions.
Main Methods:
- Human monocyte-derived DC were generated under serum-free conditions.
- DC were stimulated with MALP-2 and LPS.
- Functional properties assessed included surface marker expression, endocytosis, cytokine release, and allostimulatory capacity.
- Co-culture experiments with autologous lymphocytes were performed.
Main Results:
- MALP-2 and LPS induced DC maturation markers (CD83, CD80, CD86, HLA-ABC, CD40).
- Both agonists reduced DC endocytotic capacity and induced TNF-alpha and IL-10 release; LPS also increased IL-12.
- MALP-2 and LPS boosted DC allostimulatory capacity, with MALP-2-treated DC inducing IL-4, IL-5, and IFN-gamma production in lymphocytes.
Conclusions:
- MALP-2 effectively modulates human DC function, promoting T-cell activation and cytokine production.
- MALP-2 demonstrates potential as a clinical tool for immune response modulation.
- Further research is warranted to explore MALP-2's therapeutic applications.